Active Ingredient: TADALAFIL
Proprietary Name: ALYQ
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB2
Application Number: A209942
Product Number: 001
Approval Date: Feb 5, 2019
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information